97302 ⎘
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen Internalization into the cell
HIGH THROUGHPUT METHODS FOR CHARACTERIZATION OF ANTIBODIES
#1802Pharmaceutical composition comprising anti-GRP78 antibody as active ingredient
#1803POLYPEPTIDE CONSTRUCTS FOR SUBLINGUAL ADMINISTRATION
#1804Human monoclonal antibodies to protein tyrosine kinase 7 (PTK7) and methods for using anti-PTK7 antibodies
#1805CONDITIONED CELL IMMUNIZATION
#1806Anti-mesothelin antibodies
#1807Bispecific Ligands With Binding Specificity to Cell Surface Targets and Methods of Use Therefor
#1808Polypeptide constructs including VHH directed against EGFR for intracellular delivery
#1809Antibodies with immune effector activity and that internalize in endosialin-positive cells
#1810THERAPEUTIC APPLICATIONS OF NONCOVALENT DIMERIZING ANTIBODIES
#1811Internalizing Anti-CD74 Antibodies and Methods of Use
#1812MUTANT ANTIBODIES WITH HIGH AFFINITY FOR EGFR
#1813SINGLE DOMAIN ANTIBODIES DIRECTED AGAINST EPIDERMAL GROWTH FACTOR RECEPTOR AND USES THEREFOR
#1814POLYPEPTIDE CONSTRUCTS FOR TOPICAL ADMINISTRATION
#1815POLYPEPTIDE CONSTRUCTS FOR RECTAL AND/OR VAGINAL ADMINISTRATION
#1816Anti-human dlk-1 antibody showing anti-tumor activity in vivo
#1817ANTIBODY VACCINE CONJUGATES AND USES THEREFOR
#1818Met fab and SCFV fragments
#1819Antibodies with immune effector activity and that internalize in folate receptor alpha-positive cells
#1820POLYPEPTIDE CONSTRUCTS FOR NASAL ADMINISTRATION
#1821Tetramers
#1822FILAMENTOUS BACTERIOPHAGE DISPLAYING PROTEIN AS A BINDER OF ANTIBODIES AND IMMUNOCOMPLEXES FOR DELIVERY TO THE BRAIN
#1823Treatment Of Tumors Expressing Mutant EGF Receptors
#1824TOXIN CONJUGATED EPH RECEPTOR ANTIBODIES
#1825Therapeutic compositions and methods
#1826Anti-hDlk-1 antibody having an antitumor activity in vivo
#1827HERV-K ANTIGENS, ANTIBODIES, AND METHODS
#1828ANTI-FLT3 ANTIBODIES
#1829PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASE
#1830THERAPEUTIC COMBINATIONS OF ANTI-IGF-1R ANTIBODIES AND OTHER COMPOUNDS
#1831PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASE
#1832PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASES
#1833ANTI-CD19 ANTIBODIES AND USES IN ONCOLOGY
#1834Anti-monoclonal antibody, fragments and vectors thereof, for the treatment of tumors and corresponding products
#1835AGENT, COMPOSITION AND METHOD
#1836COUPLING OF PERIPHERAL TOLERANCE TO ENDOGENOUS IL-10 PROMOTES EFFECTIVE MODULATION OF T CELLS AND AMELIORATES AUTOIMMUNE DISEASE
#1837Anti-ILT7 antibody
#1838TRANS-MEMBRANE-ANTIBODY INDUCED INHIBITION OF APOPTOSIS
#1839Methods of promoting remyelination of central nervous system axons by administrating sHIgM22
#1840Antibodies that bind to EphA2 and methods of use thereof
#1841Antibodies against amyloid beta 4 with glycosylation in the variable region
#1842ANTI-CD19 ANTIBODY THERAPY FOR TRANSPLANTATION
#18431D05 PCSK9 antagonists
#1844Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
#1845Stabilized single domain antibodies
#1846Treatment and diagnosis of cancer
#1847Targeted Delivery of Compounds Using Multimerization Technology
#1848Anti-CD70 antibody and its use for the treatment and prevention of cancer and immune disorders
#18491B20 PCSK9 antagonists
#1850COMPOSITIONS AND METHODS FOR TREATING ACTIN-MEDIATED MEDICAL CONDITIONS
#1851Recombinant monovalent antibodies and methods for production thereof
#1852Specific binding proteins and uses thereof
#1853SINGLEC-9 BINDING AGENTS
#1854Pro104 antibody compositions and methods of use
#1855Optimized Fc Variants and methods for their generation
#1856Optimized Fc Variants and Methods for Their Generation
#1857Antibodies that bind OV064 and methods of use therefor
#1858Regulation of dendritic cell functions by the DCAL-2 receptor
#1859SUPERANTIBODY SYNTHESIS AND USE IN DETECTION, PREVENTION AND TREATMENT OF DISEASE
#1860TARGETED THERAPEUTIC PROTEINS
#1861B7-H3L cell surface antigen and antibodies that bind thereto
#1862Anti-Mesothelin Antibodies
#1863Antibodies and related molecules that bind to PSCA proteins
#1864USES OF ANTI-CD40 ANTIBODIES
#1865Targeted protein replacement for the treatment of lysosomal storage disorders
#1866Nanostructures, methods of synthesizing thereof, and methods of use thereof
#1867Nucleolin-mediated cancer diagnostics and therapy
#1868Anti-αβantibodies
#1869Antibodies and related molecules that bind to PSCA proteins
#1870USE OF A PREPARATION BASED ON AN ANTIBODY DIRECTED AGAINST A TUMOR-ASSOCIATED GLYCOSYLATION
#1871Compounds, Compositions and Methods for the Endocytic Presentation of Immunosuppressive Factors
#1872Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
#1873Antibodies that bind human dendritic and epithelial cell 205 (DEC-205)
#1874Antibodies and related molecules that bind to 24P4C12 proteins
#1875METHODS, COMPOSITIONS, AND KITS RELATING TO CHITINASES AND CHITINASE-LIKE MOLECULES AND INFLAMMATORY DISEASE
#1876Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
#1877Antigen
#1878Anti-EGFR antibodies with an improved anti-tumor activity and compositions and articles of manufacture comprising same
#1879Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
#1880Immunotherapy Regimes Dependent On APOE Status
#1881Methods, compositions, and kits relating to chitinases and chitinase-like molecules and inflammatory disease
#1882Methods, compositions, and kits relating to chitinases and chitinase-like molecules and inflammatory disease
#1883PREVENTIVE OR THERAPEUTIC AGENT CONTAINING ANTI THIOREDOXIN ANTIBODY POLYPEPTIDE AS AN ACTIVE INGREDIENT FOR DISORDERS
#1884Antibodies against CD38 for treatment of multiple myeloma
#1885CD19 antibodies and their uses
#1886Optimized Fc Variants and Methods for Their Generation
#1887EPHB3-specific antibody and uses thereof
#1888Specific binding proteins and uses thereof
#1889Methods for identifying substances for the treatment of Alzheimer's disease
#1890CD19 binding agents and uses thereof
#1891OVR110 ANTIBODY COMPOSITIONS AND METHODS FOR USE
#1892Methods and compositions for inhibiting CD32B expressing cells
#1893COMPOSITIONS THAT BIND MULTIPLE EPITOPES OF IGF-1R
#1894MOLECULES INVOLVED IN SYNAPTOGENESIS AND USES THEREFOR
#1895outer membrane protein PA0427
#1896Cysteine engineered anti-TENB2 antibodies and antibody drug conjugates
#1897Antibodies against GPR64 and uses thereof
#1898Monoclonal antibodies against activated protein C
#1899Methods of selecting internalizing antibodies
#1900PSCA: prostate stem cell antigen and distinguishing androgen receptor negative prostate cancer from benign prostatic hyperplasia
#1901Human binding molecules having killing activity against staphylococci and uses thereof
#1902Methods and compositions for treatment and diagnosis of fibrosis, tumor invasion, angiogenesis, and metastasis
#1903Modulating inflammasome activity and inflammation in the central nervous system
#1904Anti-IGF-1R Antibodies and Uses Thereof
#1905Optimized Fc variants and methods for their generation
#1906Orally Deliverable and Anti-Toxin Antibodies and Methods for Making and Using Them
#1907Human monoclonal antibodies against CD25
#1908METHODS OF THERAPY AND DIAGNOSIS USING TARGETING OF CELLS THAT EXPRESS KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR-LIKE PROTEINS
#1909Optimized Fc variants and methods for their generation
#1910Novel receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
#1911AUTOPHILIC ANTIBODIES
#1912Human monoclonal antibodies to O8E
#1913Product
#1914Humanized antibodies that recognize beta amyloid peptide
#1915Human monoclonal antibody specific for lipopolysaccharides (LPS) of the IATS O11 serotype
#1916Compositions and Methods for the Treatment of Tumor of Hematopoietic Origin
#1917Optimized Fc variants and methods for their generation
#1918Optimized Fc variants and methods for their generation
#1919ANTIBODIES TO INSULIN-LIKE GROWTH FACTOR RECEPTOR
#1920Anti-MCP-1 antibodies, compositions, methods and uses
#1921Monoclonal antibodies against prostate specific membrane antigen (PSMA) lacking in fucosyl residues
#1922Human monoclonal antibodies to programmed death ligand 1 (PD-L1)
#1923Immunoglobulin insertions, deletions and substitutions
#1924Compositions and methods for the treatment of tumor of hematopoietic origin
#1925LOX and LOXL2 inhibitors and uses thereof
#1926Methods of Therapy and Diagnosis Using Immunotargeting of CD84Hy1-expressing Cells
#1927BLOOD-BRAIN BARRIER EPITOPES AND USES THEREOF
#1928Antibody inhibiting infection of papillomavirus
#1929Optimized Fc variants
#1930Monoclonal antibodies and single chain antibody fragments against cell-surface prostate specific membrane antigen
#1931Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (SCLS)
#1932Monoclonal Antibodies and Cell Surface Antigens for the Detection and Treatment of Small Cell Lung Cancer (SCLC)
#1933Compositions and Methods for Targeted Delivery of Factors
#1934Method for targeting lysosomal enzymes
#1935NOVEL METHODS OF CANCER DIAGNOSIS AND THERAPY TARGETED AGAINST A CANCER STEM LINE
#1936Methods of cancer diagnosis and therapy targeted against a cancer stem line
#1937Human monoclonal antibodies to CD70
#1938Antibodies directed to the mammalian EAG1 ion channel protein
#1939NOVEL METHODS OF CANCER DIAGNOSIS AND THERAPY TARGETED AGAINST A CANCER STEM LINE
#1940NOVEL METHODS OF CANCER DIAGNOSIS AND THERAPY TARGETED AGAINST A CANCER STEM LINE
#1941COMBINATION METHODS OF INHIBITING TUMOR GROWTH WITH A VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR ANTAGONIST
#1942Combination methods of inhibiting tumor growth with a vascular endothelial growth factor receptor antagonist
#1943Anti-rhesus D recombinant polyclonal antibody
#1944Scavenger Receptor B1 (Cla-1) Targeting for the Treatment of Infection, Sepsis and Inflammation
#1945Methods of cancer diagnosis and therapy targeted against a cancer stem line
#1946Fc Variants Having Decreased Affinity for FcyRIIb
#1947Prostate cancer specific internalizing human antibodies
#1948PHARMACEUTICAL COMPOUND FOR BLOCKING THE CRT OR ERP57 TRANSLOCATION
#1949Methods for inhibiting the growth of cancer cells expressing PSCA
#1950NOVEL METHODS OF CANCER DIAGNOSIS AND THERAPY TARGETED AGAINST A CANCER STEM LINE
#1951PROTECTIVE STAPHYLOCOCCUS AUREUS VACCINE BASED ON CELL WALL-ASSOCIATED PROTEINS
#1952MULTIVALENT ANTIBODIES AND USES THEREFOR
#1953Methods and compositions involving polymeric immunoglobulin fusion proteins
#1954Humanized anti-amyloid antibody
#1955Optimized Fc Variants and Methods for Their Generation
#1956Intranuclear protein transduction through a nucleoside salvage pathway
#1957Anti-αβantibodies and uses thereof
#1958HUMANIZED ANTIBODIES THAT RECOGNIZE BETA AMYLOID PEPTIDE
#1959Anti-LFL2 Antibodies for the Diagnosis, Prognosis and Treatment of Cancer
#1960Use of anti-mortalin 2 antibody and functional nucleic acid for cancer therapies
#1961OPTIMIZED ANTIBODIES THAT TARGET CD19
#1962Modulation of Nkg2d
#1963Anti-EphB2 antibodies and methods using same
#1964Prevention and treatment of amyloidogenic diseases
#1965Prevention and treatment of amyloidogenic diseases
#1966Anti-ROBO4 antibodies and uses therefor
#1967TES7 and antibodies that bind thereto
#1968Humanized antibodies that recognize beta amyloid peptide
#1969Antibody-avidin fusion proteins as cytotoxic drugs
#1970Method of inhibiting infection by HCV, other flaviviridae viruses, and any other virus that complexes to low density lipoprotein or to very low density lipoprotein in blood preventing viral entry into a cell
#1971METHODS AND COMPOSITIONS FOR TREATMENT OF IMMUNE DYSFUNCTION DISORDERS
#1972Fc variants with optimized Fc receptor binding properties
#1973Targeting Poly-Gamma-Glutamic Acid to Treat Staphylococcus Epidermidis and Related Infections
#1974NOVEL GLYCOSYLATED PEPTIDE TARGET IN NEOPLASTIC CELLS
#1975Immunogenic compositions comprising progastrin and uses thereof
#1976Optimized Fc Variants and Methods for Their Generation
#1977Antibodies against cancer antigen TMEFF2 and uses thereof
#1978Methods of modulating CD200 receptors
#1979Internalizing anti-CD74 antibodies and methods of use
#1980Fc Variants with Increased Affinity for FcyRIIc
#1981Methods For Reducing the Symptoms of Autoimmunity and Inflammation Using Binding Proteins Against Antigens Exposed on Dead or Dying Cells
#1982Antibodies against cancer antigen TMEFF2 and uses thereof
#1983Fc variants with increased affinity for FcγRIIc
#1984Method of delivering RNA interference and uses thereof
#1985Assays for rab5 activity
#1986Isolated Broadly Reactive Opsonic Immunoglobulin for Treating a Pathogenic Coagulase-Negative Staphylococcus Infection
#1987METHODS AND COMPOSITIONS FOR MODULATING THE IMMUNE SYSTEM OF ANIMALS
#1988Humanized anti-CD19 antibodies and their use in treatment of oncology, transplantation and autoimmune disease
#1989Internalizing anti-CD74 antibodies and methods of use
#1990Method of treating a pathological syndrome and a pharmaceutical agent
#1991Fragments of antibodies to epidermal growth factor receptor and methods of their use
#1992EXPRESSION OF FUNCTIONAL ANTIBODY FRAGMENTS
#1993Antibodies directed to HER-3 and uses thereof
#1994Anti-TAT188 antibodies
#1995Conditioned Cell Immunization
#1996Naturally occuring IgM antibodies that bind lymphocytes
#1997Naturally occurring IgM antibodies that bind lymphocytes
#1998Internalizing ErbB2 antibodies
#1999Adenocarcinoma specific antibody SAM-6, and uses thereof
#2000Antibodies against GPR64 and uses thereof
#2001Human monoclonal antibodies to Fc gamma receptor I (CD64)
#2002Immunotoxins directed against CD33 related surface antigens
#2003Inhibitors of Dkk-1
#2004Monovalent ligand of the FcαRI receptor as an anti-inflammatory agent
#2005Antibody
#2006Fc Variants with Increased Affinity for FcyRIIC
#2007Modulation of Phagocytosis in Neurons
#2008Fc Variants with Increased Affinity for FcyRIIc
#2009Method of treating a pathological syndrome and a pharmaceutical agent
#2010Humanized antibodies that recognize beta amyloid peptide
#2011Method of treating a pathological syndrome and a pharmaceutical agent
#2012Antibodies and immunoconjugates and uses therefor
#2013Antibodies against cancer antigen TMEFF2 and uses thereof
#2014Combination therapies for B-cell lymphomas comprising administration of anti-CD20 antibody
#2015Fully human antibodies directed against the human insulin-like growth factor-1 receptor
#2016Method of treating a pathological syndrome and a pharmaceutical agent
#2017Blood-brain barrier targeting antibodies
#2018Method of treating a pathological syndrome and a pharmaceutical agent
#2019Nucleic acids encoding opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
#2020Multifunctional monoclonal antibodies directed to peptidoglycan of gram-positive bacteria
#2021Methods and compositions for the treatment of prostate cancer
#2022Polypeptide fragments of CKLF1
#2023CD44E tumor specific antibody
#2024Anti-CD70 antibody and its use for the treatment and prevention of cancer and immune disorders
#2025Fc Variants Having Decreased Affinity for FcyRl
#2026Treatment of tumors expressing mutant EGF receptors
#2027Compositions and methods for the treatment of tumor of hematopoietic origin
#2028Compositions and methods for treating B-cell malignancies
#2029Methods of Therapy and Diagnosis Using Targeting of Cells that Express Killer Cell Immunoglobulin like Receptor like Proteins
#2030Humanized anti-CD22 antibodies and their use in treatment of oncology, transplantation and autoimmune disease
#2031Humanized c-Kit antibody
#2032Mannose binding lectin knock-out mice and methods of use thereof
#2033Fc Variants with Increased Affinity for FcyRlla
#2034Fc variants having increased affinity for fcyrllc
#2035Anti-IGF-1R antibodies and uses thereof
#2036Fc Variants Having Decreased Affinity for FcyRlla
#2037Fc Variants Having Decreased Affinity for FcyRIIc
#2038Humanized antibodies that recognize β-amyloid peptide
#2039Fc Variants Having Decreased Affinity for FcyRllla
#2040Fc Variants Having Increased Affinity for FcyRllla
#2041Fc Variants Having Increased Affinity for FcyRl
#2042Methods of Redistributing Apical Target Antigens to Detect and Treat Cellular Proliferative Disease
#2043Anti-5T4 antibodies and uses thereof
#2044Fc variants
#2045OPTIMIZED Fc VARIANTS AND METHODS FOR THEIR GENERATION
#2046CD20 OPTIMIZED Fc VARIANTS AND METHODS FOR THEIR GENERATION
#2047Method of treating a pathological syndrome and a pharmaceutical agent
#2048CD52 OPTIMIZED Fc VARIANTS AND METHODS FOR THEIR GENERATION
#2049COUPLING OF PERIPHERAL TOLERANCE TO ENDOGENOUS IL-10 PROMOTES EFFECTIVE MODULATION OF T CELLS AND AMELIORATES AUTOIMMUNE DISEASE
#2050Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer
#2051COMPOSITIONS AND METHODS FOR THE TREATMENT OF TUMOR OF HEMATOPOIETIC ORIGIN
#2052Cell-Targeted IKB and Methods for the Use Thereof
#2053Her2/neu OPTIMIZED Fc VARIANTS AND METHODS FOR THEIR GENERATION
#2054Methods of identifying combinations of antibodies with an improved anti-tumor activity and compositions and methods using the antibodies
#2055Ovr110 antibody compositions and methods of use
#2056IMMUNOCONJUGATES AND HUMANIZED ANTIBODIES SPECIFIC FOR B-CELL LYMPHOMA AND LEUKEMIA CELLS
#2057Immunizing compostion and method for inducing an immune response against the beta-secretase cleavage site of amyloid precursor protein
#2058Hybrid proteins of active-site serine β-lactamase
#2059Optimized Fc variants and methods for their generation
#2060Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
#2061Humanized antibodies that recognize beta amyloid peptide
#2062Fc Variants With Optimized Fc Receptor Binding Properties
#2063METHOD OF DIAGNOSING ALZHEIMER'S DISEASE BY DETECTION OF CHLAMYDIA PNEUMONIAE
#2064Method for diagnosis of alzheimer's disease
#2065Antibodies that bind to cancer-associated antigen CD46 and methods of use thereof
#2066Compounds, Compositions and Methods for the Endocytic Presentation of Immunosuppressive Factors
#2067Isolated mammalian membrane proteins; related agents
#2068Ovr115 antibody compositions and methods of use
#2069Antibodies against the tenascin major antigens
#2070Preventing bacterial or viral infectivity and composition containing infection preventing additive
#2071Pro104 antibody compositions and methods of use
#2072Polynucleotides, polypeptides and antibodies and use thereof in treating tsg101-associated diseases
#2073Enhancement of intracellular delivery and tissue targeting of drugs and genes
#2074Human monoclonal antibodies to activin receptor-like kinase-1
#2075Optimized Fc variants and methods for their generation
#2076Novel methods of cancer diagnosis and therapy targeted against a cancer stem line
#2077Novel methods of cancer diagnosis and therapy targeted against a cancer stem line
#2078Novel methods of cancer diagnosis and therapy targeted against a cancer stem line
#2079Methods of cancer diagnosis and therapy targeted against a cancer stem line
#2080Methods of cancer diagnosis and therapy targeted against a cancer stem line
#2081Methods of cancer diagnosis and therapy targeted against a cancer stem line
#2082Medicament for the protection against thrombotic diseases
#2083Therapeutic agent for periodontal disease
#2084Immunoliposomes that optimize internationalization into target cells
#2085Optimized Fc variants and methods for their generation
#2086Tumor-associated marker
#2087Tomoregulin antibodies and uses thereof
#2088High affinity human antibodies to tumor antigens
#2089Humanized antibodies that recognize beta amyloid peptide
#2090Anti-CD19 antibody therapy for transplantation
#2091GLP-1 receptor agonist and allosteric modulator monoclonal antibodies and uses thereof
#2092Treatment and diagnosis of cancer
#2093Antibodies and related molecules that bind to 161P2F10B proteins
#2094Targeted chimeric molecules for cancer therapy
#2095Anti-CD19 antibody therapy for autoimmune disease
#2096Nucleolin-mediated cancer diagnostics and therapy
#2097Methods and compositions for treating a subject having an anthrax toxin mediated condition
#2098Human binding molecule against CD1a
#2099Abeta antibodies for use in improving cognition
#2100Methods of modulating CD200 receptors